相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting RAGE prevents muscle wasting and prolongs survival in cancer cachexia
Sara Chiappalupi et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2020)
High Mobility Group Box 1 in Human Cancer
Bernardo L. Rapoport et al.
CELLS (2020)
Advancement of NF-B Signaling Pathway: A Novel Target in Pancreatic Cancer
Kartick C. Pramanik et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
RAGE in the pathophysiology of skeletal muscle
Francesca Riuzzi et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2018)
RAGE maintains high levels of NFκB and oncogenic Kras activity in pancreatic cancer
Nancy Azizan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Drug resistance in pancreatic cancer: Impact of altered energy metabolism
Cristoforo Grasso et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
Cancer Statistics, 2016
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
The Landscape of Pancreatic Cancer Therapeutic Resistance Mechanisms
Saswati Chand et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2016)
The Regulation of NF-κB Subunits by Phosphorylation
Frank Christian et al.
CELLS (2016)
The role of S100 proteins and their receptor RAGE in pancreatic cancer
Estelle Leclerc et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
HMGB1-mediated autophagy modulates sensitivity of colorectal cancer cells to oxaliplatin via MEK/ERK signaling pathway
Weijun Liu et al.
CANCER BIOLOGY & THERAPY (2015)
Gemcitabine resistance in pancreatic ductal adenocarcinoma
Yoav Binenbaum et al.
DRUG RESISTANCE UPDATES (2015)
Abstract B96: The HMGB1/RAGE inflammatory pathway promotes pancreatic tumor growth by regulating mitochondrial bioenergetics.
Rui Kang et al.
CANCER RESEARCH (2014)
The receptor for advanced glycation end products influences the expression of its S100 protein ligands in melanoma tumors
Varsha Meghnani et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2014)
HMGB1 in health and disease
Rui Kang et al.
MOLECULAR ASPECTS OF MEDICINE (2014)
Self-consumption: the interplay of autophagy and apoptosis
Guillermo Marino et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Critical role of NF-κB in pancreatic cancer
Lakshmi Prabhu et al.
ONCOTARGET (2014)
RAGE in tissue homeostasis, repair and regeneration
Guglielmo Sorci et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)
Phagocyte-derived S100 proteins in autoinflammation: Putative role in pathogenesis and usefulness as biomarkers
Christoph Kessel et al.
CLINICAL IMMUNOLOGY (2013)
Functions of S100 Proteins
R. Donato et al.
CURRENT MOLECULAR MEDICINE (2013)
RAGE is a nucleic acid receptor that promotes inflammatory responses to DNA
Cherilyn M. Sirois et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
ERK1/2 activity contributes to gemcitabine resistance in pancreatic cancer cells
Chunning Zheng et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2013)
Designing and Developing S100P Inhibitor 5-Methyl Cromolyn for Pancreatic Cancer Therapy
Thiruvengadam Arumugam et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Novel Pancreatic Cancer Cell Lines Derived from Genetically Engineered Mouse Models of Spontaneous Pancreatic Adenocarcinoma: Applications in Diagnosis and Therapy
Maria P. Torres et al.
PLOS ONE (2013)
AGER/RAGE-mediated autophagy promotes pancreatic tumorigenesis and bioenergetics through the IL6-pSTAT3 pathway
Rui Kang et al.
AUTOPHAGY (2012)
RAGE binds C1q and enhances C1q-mediated phagocytosis
Wanchao Ma et al.
CELLULAR IMMUNOLOGY (2012)
S100P-Derived RAGE Antagonistic Peptide Reduces Tumor Growth and Metastasis
Thiruvengadam Arumugam et al.
CLINICAL CANCER RESEARCH (2012)
Receptor for Advanced Glycation End Products (RAGE) Functions as Receptor for Specific Sulfated Glycosaminoglycans, and Anti-RAGE Antibody or Sulfated Glycosaminoglycans Delivered in Vivo Inhibit Pulmonary Metastasis of Tumor Cells
Shuji Mizumoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
RAGE Gene Deletion Inhibits the Development and Progression of Ductal Neoplasia and Prolongs Survival in a Murine Model of Pancreatic Cancer
Joseph DiNorcia et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2012)
The expression of the receptor for advanced glycation endproducts (RAGE) is permissive for early pancreatic neoplasia
Rui Kang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Deconvoluting the context-dependent role for autophagy in cancer
Eileen White
NATURE REVIEWS CANCER (2012)
S100P: a novel therapeutic target for cancer
Thiruvengadam Arumugam et al.
AMINO ACIDS (2011)
Acquisition of chemoresistance in intrahepatic cholangiocarcinoma cells by activation of AKT and extracellular signal-regulated kinase (ERK)1/2
Hyunho Yoon et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
HMGB1-induced autophagy promotes chemotherapy resistance in leukemia cells
L. Liu et al.
LEUKEMIA (2011)
Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease
Velandai Srikanth et al.
NEUROBIOLOGY OF AGING (2011)
RAGE: a single receptor fits multiple ligands
Guenter Fritz
TRENDS IN BIOCHEMICAL SCIENCES (2011)
TGF-β downregulates PTEN via activation of NF-κB in pancreatic cancer cells
Jimmy Y. C. Chow et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2010)
HMGB1 and RAGE in Inflammation and Cancer
Gary P. Sims et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
High-mobility group box 1 and cancer
Daolin Tang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2010)
The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival
R. Kang et al.
CELL DEATH AND DIFFERENTIATION (2010)
Lack of an Endogenous Anti-inflammatory Protein in Mice Enhances Colonization of B16F10 Melanoma Cells in the Lungs
Arjun Saha et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Tempering the wrath of RAGE: An emerging therapeutic strategy against diabetic complications, neurodegeneration, and inflammation
Shi Fang Yan et al.
ANNALS OF MEDICINE (2009)
Binding of S100 proteins to RAGE: An update
Estelle Leclerc et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2009)
Control of autophagy by oncogenes and tumor suppressor genes
M. C. Maiuri et al.
CELL DEATH AND DIFFERENTIATION (2009)
Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications
A. Bierhaus et al.
DIABETOLOGIA (2009)
Activation of Nrf2-antioxidant signaling attenuates NFκB-inflammatory response and elicits apoptosis
Wenge Li et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Autophagy in the pathogenesis of disease
Beth Levine et al.
CELL (2008)
RAGE signaling sustains inflammation and promotes tumor development
Christoffer Gebhardt et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains
Estelle Leclerc et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
High mobility group box I (HMGB1) release from tumor cells after treatment: Implications for development of targeted chemoimmunotherapy
Xiang Da (Eric) Dong et al.
JOURNAL OF IMMUNOTHERAPY (2007)
The MEK/ERK cascade: From signaling specificity to diverse functions
Yoav D. Shaul et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2007)
S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules
Dirk Foell et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
ERK1/2 is highly phosphorylated in melanoma metastases and protects melanoma cells from cisplatin-mediated apoptosis
Alireza Mirmohammadsadegh et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
RAGE and RAGE ligands in cancer
Craig D. Logsdon et al.
CURRENT MOLECULAR MEDICINE (2007)
RAGE: A single receptor for several ligands and different cellular responses: The case of certain S100 proteins
Rosario Donato
CURRENT MOLECULAR MEDICINE (2007)
Effect of cromolyn on S100P interactions with RAGE and pancreatic cancer growth and invasion in mouse models
Thiruvengadam Arumugam et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Understanding RAGE, the receptor for advanced glycation end products
A Bierhaus et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2005)
S100P promotes pancreatic cancer growth, survival, and invasion
T Arumugam et al.
CLINICAL CANCER RESEARCH (2005)
Coactivators and corepressors of NF-κB in IκΒα gene promoter
ZG Gao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Phosphorylation of NF-kappa B and I kappa B proteins: implications in cancer and inflammation
P Viatour et al.
TRENDS IN BIOCHEMICAL SCIENCES (2005)
Modulation of AP-1 by natural chemopreventive compounds in human colon HT-29 cancer cell line
WS Jeong et al.
PHARMACEUTICAL RESEARCH (2004)
S100P stimulates cell proliferation and survival via receptor for activated glycation end products (RAGE)
T Arumugam et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Mechanisms of caspase activation and inhibition during apoptosis
YG Shi
MOLECULAR CELL (2002)
Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-κB transcriptional activation and cytokine secretion
CH Yeh et al.
DIABETES (2001)
The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-α through nuclear Factor-κB, and by 17β-estradiol through Sp-1 in human vascular endothelial cells
N Tanaka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases
A Taguchi et al.
NATURE (2000)
RAGE: A multiligand receptor contributing to the cellular response in diabetic vasculopathy and inflammation
AM Schmidt et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2000)
分享论文
